GlycoMimetics Inc (GLYC)
0.2768
-0.01
(-2.57%)
USD |
NASDAQ |
Jan 08, 16:00
0.2731
0.00 (0.00%)
After-Hours: 20:00
GlycoMimetics Enterprise Value: 3.458M for Jan. 8, 2025
View 4,000+ Financial Data Types:
Add
Browse
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
Biomarin Pharmaceutical Inc | 12.70B |
Arbutus Biopharma Corp | 507.00M |
Revance Therapeutics Inc | 602.73M |
FibroGen Inc | 49.32M |
Cidara Therapeutics Inc | 144.93M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -9.824M |
Total Expenses (Quarterly) | 5.721M |
EPS Diluted (Quarterly) | -0.15 |
Earnings Yield | -224.0% |
Normalized Earnings Yield | -209.54 |